HishamMohamedAbdel-AzimMD
Pediatric Hematology & Oncology • Los Angeles, CAAssistant Professor, Pediatrics, USC School of Medicine
Are you Dr. Abdel-Azim?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 54 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4650 W Sunset Blvd
Ms# 62
Los Angeles, CA 90027Phone+1 323-669-4559Fax+1 323-660-1904- Is this information wrong?
Summary
- Dr. Hisham Abdel-Azim, MD is a pediatric hematologist/oncologist in Los Angeles, California. He is currently licensed to practice medicine in California and Maine. He is affiliated with Children's Hospital Los Angeles and City of Hope Comprehensive Cancer Center.
Education & Training
Children's Hospital Los AngelesFellowship, Pediatric Hematology/Oncology, 2002 - 2005
Westchester Medical CenterResidency, Pediatrics, 2000 - 2002
Cairo University School of MedicineClass of 1993
Certifications & Licensure
CA State Medical License 2002 - 2026
ME State Medical License 2007 - 2020- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells Start of enrollment: 2008 Aug 01
- Study to Assess the Safety and Efficacy of Brincidofovir in Treatment of Early Versus Late Adenovirus Infection Start of enrollment: 2014 Mar 01
- The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL Start of enrollment: 2018 Aug 29
Publications & Presentations
PubMed
- Predictive value of early molecular response to tyrosine kinase inhibitors in pediatric patients with chronic myeloid leukemia.Aya M Abdallah, Hanafy Hafez, Youssef Madney, Sonia Ahmed, Dina Yassin, Sherine Salem, Rodina Yousry, Leslie Lehmann, Alaa Elhaddad, Hisham Abdel-Azim> ;Leukemia & Lymphoma. 2024 Mar 21
- Posttransplantation late complications increase over time for patients with SCID: A Primary Immune Deficiency Treatment Consortium (PIDTC) landmark study.Eissa, H., Thakar, M., Shah, A., Logan, B., Griffith, L., Dong, H., Parrott, R., O'Reilly, R., Dara, J., Kapoor, N., Forbes Satter, L., Chandra, S., Kapadia, M., Chand...> ;The Journal of Allergy and Clinical Immunology. 2024 Jan 1
- 4 citationsGenotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD.Jennifer W Leiding, Danielle E Arnold, Suhag Parikh, Brent Logan, Rebecca A Marsh, Linda M Griffith, Ruizhe Wu, Sharon Kidd, Kanwaldeep Mallhi, Deepak Chellapandian, S...> ;Blood. 2023 Dec 14
- Join now to see all
Press Mentions
- Study: Emerging Method of Stem Cell Transplantation Improves Outcomes in Children with Blood CancersJuly 14th, 2022
Obese Children with Leukemia Fared Worse in Study - US NewsOctober 27th, 2014- Loma Linda University Health’s Cell Therapy Division Receives AccreditationMarch 22nd, 2024
Professional Memberships
- Member
Hospital Affiliations
Children's Hospital Los AngelesLos Angeles, California
City of Hope Comprehensive Cancer CenterDuarte, California
